Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of this study is to assess the safety and reactogenicity of a single intramuscular dose of GSK Biologicals\' investigational RSV vaccine, in healthy, non-pregnant women aged 18 to 45 years.
Epistemonikos ID: 36e5afcf84da99a1f75fdd2171cc53ffacb37a2f
First added on: Sep 12, 2018